Stock Events

Stock Events

BioPharma Credit 

€0.8300
143
-€0.01-0.6% Friday 19:56

Statistics

Day High
0.83
Day Low
0.81
52W High
0.83
52W Low
0.81
Volume
-
Avg. Volume
-
Mkt Cap
0
P/E Ratio
-
Dividend Yield
7.35%
Dividend
0.06

Upcoming

2
JUL
Dividend Ex
Increased
 
31
JUL
Dividend Payment
Increased
 
25
SEP
Dividend Ex
Estimated
 
30
OCT
Dividend Payment
Estimated
 
19
FEB 27
Dividend Ex
Estimated
 
19
MAR 27
Dividend Payment
Estimated
 

Dividends

7.35%Dividend Yield
May 26
€0.01
Mar 26
€0.01
Mar 26
€0.01
Oct 25
€0.01
Oct 25
€0.02
10Y Growth
N/A
5Y Growth
0.41%
3Y Growth
-1.69%
1Y Growth
-3.16%

People Also Follow

This list is based on the watchlists of people on Stock Events who follow B3P.STU. It's not an investment recommendation.

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
BridgeBio Pharma
BBIO
Mkt Cap13.08B
BridgeBio Pharma focuses on genetic diseases and competes in the biopharma financing space by attracting investments for its projects.
Pfizer
PFE
Mkt Cap149.38B
Pfizer is a large pharmaceutical company with a significant investment arm for biopharma ventures, competing for similar investment opportunities.
Gilead Sciences
GILD
Mkt Cap155.93B
Gilead Sciences invests in biopharma companies and projects, directly competing with BioPharma Credit's investment model.
Bristol-Myers Squibb
BMY
Mkt Cap116.66B
Bristol Myers Squibb, through its venture arm, competes in the biopharma credit and investment space.
Merck
MRK
Mkt Cap294.03B
Merck & Co., with its venture capital initiatives, competes for similar biopharma investments and financing opportunities.
Johnson & Johnson
JNJ
Mkt Cap579.83B
Johnson & Johnson, through its J&J Innovation and JLABS units, competes in the biopharma investment and financing space.
Abbvie
ABBV
Mkt Cap402.35B
AbbVie, with its venture investment arm, competes for opportunities in biopharma credit and financing.
AMGEN
AMGN
Mkt Cap191.7B
Amgen, through its venture investments, competes in the biopharma financing space, targeting similar companies and projects.
Novartis
NVS
Mkt Cap292.07B
Novartis, with its significant investments in biopharma companies, competes directly with BioPharma Credit's financing model.
Sanofi
SNY
Mkt Cap105.92B
Sanofi, through its venture capital arm, competes in the biopharma credit market, financing similar types of companies and projects.

About

Operating as an investment trust, BioPharma Credit PLC primarily allocates its capital to debt instruments that generate interest. The security for these investments is provided by royalties or other cash streams originating from the commercial sale of approved life sciences products. This company was established in 2016 and its headquarters are situated in Exeter, United Kingdom.
Show more...
CEO
ISIN
GB00BDGKMY29

Listings

MU
DE
B3P.MU
STU
DE
B3P.STU
LSE
GB
BPCP.LSE
LSE
GB
BPCR.LSE

0 Comments

Share your thoughts

FAQ

What is BioPharma Credit stock price today?▼
The current price of B3P.STU is €0.83 EUR — it has decreased by -0.6% in the past 24 hours. Watch BioPharma Credit stock price performance more closely on the chart.
What is BioPharma Credit stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on exchange BioPharma Credit stocks are traded under the ticker B3P.STU.
Does BioPharma Credit pay dividends?▼
Yes, B3P.STU dividends are paid quarterly. The last dividend per share was 0.01 EUR. As of today, Dividend Yield (FWD)% is 7.35%.
In which sector is BioPharma Credit located?▼
BioPharma Credit operates in the Other sector.
When did BioPharma Credit complete a stock split?▼
BioPharma Credit has not had any recent stock splits.